Navigation Links
Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
Date:5/3/2011

Clinical

  • Enrollment and site initiations continue according to the Company's estimated timelines in the PEARL-SC study.  Active enrollment is underway in the following countries: United States, Mexico, Peru, Chile, the Philippines, Argentina and Colombia. PEARL-SC is examining the therapeutic benefit of A-623, which utilizes a subcutaneous formulation and modulates both soluble and membrane-bound BAFF in patients with systemic lupus erythematosus (lupus). The primary endpoint of the PEARL-SC study is an SLE responder index (SRI). Details regarding the study can be found at http://www.clinicaltrials.gov/ct2/show/NCT01162681.
  • The PEARL-SC open label extension protocol has been submitted to FDA. This would allow Anthera to capture important long term safety data and optimize enrollment by giving study subjects an option to continue participation on active therapy beyond the PEARL-SC duration.
  • In the Phase 3 VISTA-16 study, enrollment surpassed the 1000 patient threshold during the first quarter, triggering a pre-defined, blinded biomarker analysis conducted by an independent statistician. The statistician examined four predefined biomarkers of cardiovascular risk and one composite responder index including sPLA2, IL-6, CRP, LDL-C and a composite analysis comparing the proportion of patients achieving an LDL-C < 70 and a CRP < 1. Subsequent to the end of the first quarter, the Company announced a favorable outcome from the biomarker analysis. The VISTA-16 clinical study is designed to reduce inflammation and the risk of subsequent secondary Major Adverse Cardiovascular Events (MACE) in high-risk patients following an ACS. Details regarding the study can be found at http://www.clinicaltrials.gov/ct2/show/NCT01130246. The next substantial review of clinical safety and efficacy data is planned once 50
    '/>"/>

  • SOURCE Anthera Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
    2. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
    3. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
    4. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
    5. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
    6. Anthera Announces Update Call Regarding Vial Problems
    7. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
    8. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
    9. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
    10. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
    11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) ... Rental and Leasing - Global Strategic Business Report" ... the worldwide markets for Medical Equipment Rental and Leasing ... for the US, Japan , ... Annual estimates and forecasts are provided for the ...
    (Date:4/17/2015)... , April 17, 2015  In Detroit, where three ... mortality rate is two and one half times of the ... 6 of 10 infants that die in Detroit ... sobering statistics that Covenant Community Care, a faith-based, charitable non-profit ... poised to change thanks to a charitable donation by Konica ...
    (Date:4/17/2015)... DALLAS , Apr. 17, 2015 Steven ... ( ALGA ), and its operating subsidiary American Seed ... an exclusive presentation to investors yesterday in New York ... Strategy. The American Seed & Oil Company ... , Hippie Butter Hemp Seed Foods , the ...
    Breaking Medicine Technology:Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3
    ... Nov. 29, 2011 Hamamatsu Photonics introduces ... exceptional quantum efficiency and low noise, the ... cooled CCDs, and first-generation scientific CMOS cameras. ... Now one camera covers a wide range ...
    ... Ala., Nov. 28, 2011 Qualitest Pharmaceuticals today announced that ... (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 ... The total sales for Myzilra Tablets in the ... approximately $34.4 million, according to IMS Health. ...
    Cached Medicine Technology:Hamamatsu Introduces the ORCA-Flash4.0 Scientific CMOS Camera With High Sensitivity, High Resolution, and Fast Readout 2
    (Date:4/18/2015)... Omaha, NE (PRWEB) April 18, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the South Carolina Physical Therapy Association ... at the Kroc Center in Greenville, SC. ... networking opportunities, and exhibits with products and services. ...
    (Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
    (Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
    (Date:4/17/2015)... Rosetta Radiology is proud to now offer ... of diagnostic imaging services. This solidifies them as a ... East Side of Manhattan. , The new imaging equipment ... of PET-CT, combined with Rosetta’s state of the art ... with patients through several stages of the cancer care ...
    (Date:4/17/2015)... (PRWEB) April 17, 2015 Riviera ... Dr. Kevin Sadati of the Gallery of Cosmetic ... County’s top beauty experts. The publication focused on ... facial stem cell fat grafting, eyelid surgery, laser resurfacing ... facial plastic surgery has resulted in thousands of ...
    Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3
    ... (Nasdaq: AMGN ) will present at the ... May 18, 2009 at the InterContinental, Boston, Mass., beginning ... Executive Officer Kevin Sharer will present. Live audio of ... can be accessed from Amgen,s Web site, www.amgen.com ...
    ... risk by 35%, study finds , , WEDNESDAY, May ... medications may ease the symptoms of bronchiolitis -- a ... research suggests this treatment may reduce the risk of ... wheezing sooner and get babies back to normal feeding ...
    ... Plan Yields Positive ResultsCLEVELAND, May 13 DATATRAK International, ... services company focused on global eClinical solutions for the ... the first quarter of 2009. Revenue for the first ... to $2,088,000 in the same period of 2008. Gross ...
    ... VIEW, Calif., May 13 MAP Pharmaceuticals, Inc. (Nasdaq: ... at the Deutsche Bank Securities 34th Annual Health ... (ET) in Boston, MA.A live webcast of the presentation will ... website at http://www.mappharma.com . A replay will also be ...
    ... from a study of managed-care cancer patients receiving chemotherapy ... the cumulative ESA cost with Epoetin alfa (EPO) was ... The analysis, published in the Spring issue of ... by Centocor Ortho Biotech Services, LLC. The retrospective ...
    ... a lawsuit against the U.S. Patent and Trademark Office and Myriad ... as BRCA1 and BRCA2, which are indicators for hereditary predisposition to ... ... May 13, 2009 -- The College of American Pathologists today joined ...
    Cached Medicine News:Health News:Combo Treatment Eases Wheezing in Babies 2Health News:Combo Treatment Eases Wheezing in Babies 3Health News:DATATRAK International, Inc. Announces First Quarter Results for 2009 2Health News:DATATRAK International, Inc. Announces First Quarter Results for 2009 3Health News:DATATRAK International, Inc. Announces First Quarter Results for 2009 4Health News:DATATRAK International, Inc. Announces First Quarter Results for 2009 5Health News:DATATRAK International, Inc. Announces First Quarter Results for 2009 6Health News:Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa 2Health News:Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa 3Health News:Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa 4Health News:Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa 5Health News:Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa 6Health News:CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents 2
    ... Choose from a complete ... and AC halogen light ... cool illumination. A solid-state ... intensity, and our exclusive ...
    Inquire...
    ... inverted microscope technology that offers you much more ... in this category. You will be impressed by ... been designed to make lab work as easy ... efficiency of your workflow. Your advantage: more time ...
    ... represents the most advanced motorized inverted microscope ... and optical design provides 9 access ports ... to four ports can have simultaneous access ... motorized Z-axis drive, 6-position nosepiece and light ...
    Medicine Products: